[HTML][HTML] Psilocybin-enhanced fear extinction linked to bidirectional modulation of cortical ensembles

SA Rogers, EA Heller, G Corder - bioRxiv, 2024 - ncbi.nlm.nih.gov
Abstract The serotonin 2 receptor (5HT2R) agonist psilocybin displays rapid and persistent
therapeutic efficacy across neuropsychiatric disorders characterized by cognitive inflexibility …

Acute psilocybin enhances cognitive flexibility in rats

A Torrado Pacheco, RJ Olson, G Garza… - …, 2023 - nature.com
Psilocybin has been shown to improve symptoms of depression and anxiety when combined
with psychotherapy or other clinician-guided interventions. To understand the neural basis …

Psilocybin facilitates fear extinction: Importance of dose, context, and serotonin receptors

SC Woodburn, CM Levitt, AM Koester… - ACS Chemical …, 2024 - ACS Publications
A variety of classic psychedelics and MDMA have been shown to enhance fear extinction in
rodent models. This has translational significance because a standard treatment for post …

Probing the antidepressant potential of psilocybin: integrating insight from human research and animal models towards an understanding of neural circuit mechanisms

J Meccia, J Lopez, RC Bagot - Psychopharmacology, 2023 - Springer
Interest in the therapeutic potential of serotonergic psychedelic compounds including
psilocybin has surged in recent years. While human clinical research suggests psilocybin …

Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder

MK Doss, M Považan, MD Rosenberg… - Translational …, 2021 - nature.com
Psilocybin has shown promise for the treatment of mood disorders, which are often
accompanied by cognitive dysfunction including cognitive rigidity. Recent studies have …

Brain dynamics predictive of response to psilocybin for treatment-resistant depression

J Vohryzek, J Cabral, LD Lord… - Brain …, 2024 - academic.oup.com
Psilocybin therapy for depression has started to show promise, yet the underlying causal
mechanisms are not currently known. Here, we leveraged the differential outcome in …

Psilocybin analog 4-OH-DiPT enhances fear extinction and GABAergic inhibition of principal neurons in the basolateral amygdala

TJ Kelly, EM Bonniwell, L Mu, X Liu, Y Hu… - …, 2024 - nature.com
Psychedelics such as psilocybin show great promise for the treatment of depression and
PTSD, but their long duration of action poses practical limitations for patient access. 4-OH …

Psilocybin restrains activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms

K Conn, LK Milton, K Huang, H Munguba… - Molecular …, 2024 - nature.com
Psilocybin has shown promise for alleviating symptoms of depression and is currently in
clinical trials for the treatment of anorexia nervosa (AN), a condition that is characterised by …

Psilocybin prevents activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms

K Conn, LK Milton, K Huang, H Munguba, J Ruuska… - bioRxiv, 2023 - biorxiv.org
Psilocybin has shown promise for alleviating symptoms of depression and is currently in
clinical trials for the treatment of anorexia nervosa (AN), a condition that is characterised by …

[HTML][HTML] Cellular rules underlying psychedelic control of prefrontal pyramidal neurons

TG Ekins, I Brooks, S Kailasa, C Rybicki-Kler… - bioRxiv, 2023 - ncbi.nlm.nih.gov
Classical psychedelic drugs are thought to increase excitability of pyramidal cells in
prefrontal cortex via activation of serotonin 2 A receptors (5-HT2 A Rs). Here, we instead find …